These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12170085)

  • 1. Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
    Tickoo SK; Zee SY; Obiekwe S; Xiao H; Koea J; Robiou C; Blumgart LH; Jarnagin W; Ladanyi M; Klimstra DS
    Am J Surg Pathol; 2002 Aug; 26(8):989-97. PubMed ID: 12170085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas.
    Fiorentino M; D'Errico A; Altimari A; Barozzi C; Grigioni WF
    Diagn Mol Pathol; 1999 Dec; 8(4):189-94. PubMed ID: 10617275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection.
    D'Errico A; Baccarini P; Fiorentino M; Ceccarelli C; Bonazzi C; Ponzetto A; Scoazec JY; Mancini AM; Grigioni WF
    Hum Pathol; 1996 Jun; 27(6):599-604. PubMed ID: 8666372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C; Herlea V; Dragnea A; Popescu I
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA.
    Oliveira AM; Erickson LA; Burgart LJ; Lloyd RV
    Am J Surg Pathol; 2000 Feb; 24(2):177-82. PubMed ID: 10680884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
    Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
    Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites.
    Nasir A; Lehrke HD; Mounajjed T; Said S; Zhang L; Yasir S; Shah SS; Chandan VS; Smyrk TC; Moreira RK; Boland Froemming JM; Herrera Hernandez LP; Wu TT; Graham RP
    Am J Clin Pathol; 2019 Jul; 152(2):190-199. PubMed ID: 31107526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2017 Feb; 70(3):423-434. PubMed ID: 27634656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
    Shirakawa H; Kuronuma T; Nishimura Y; Hasebe T; Nakano M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
    Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
    Terracciano LM; Glatz K; Mhawech P; Vasei M; Lehmann FS; Vecchione R; Tornillo L
    Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.
    Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
    Goodman ZD; Ishak KG; Langloss JM; Sesterhenn IA; Rabin L
    Cancer; 1985 Jan; 55(1):124-35. PubMed ID: 2578078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.
    Itoyama M; Hata M; Yamanegi K; Yamada N; Ohyama H; Hirano H; Terada N; Nakasho K
    Med Mol Morphol; 2012 Dec; 45(1):7-13. PubMed ID: 22431178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
    Xu J; Zhang C; Qiao A; Xi Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
    Ferrone CR; Ting DT; Shahid M; Konstantinidis IT; Sabbatino F; Goyal L; Rice-Stitt T; Mubeen A; Arora K; Bardeesey N; Miura J; Gamblin TC; Zhu AX; Borger D; Lillemoe KD; Rivera MN; Deshpande V
    Ann Surg Oncol; 2016 Jan; 23(1):290-6. PubMed ID: 25519926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features.
    Maeda T; Adachi E; Kajiyama K; Sugimachi K; Tsuneyoshi M
    Hum Pathol; 1995 Sep; 26(9):956-64. PubMed ID: 7545644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic features of combined hepatic carcinoma].
    He C; Yin HF; Liu P; Zhang Y; Zhang JB
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):824-8. PubMed ID: 24507101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinicopathological study on combined hepatocellular and cholangiocarcinoma.
    Taguchi J; Nakashima O; Tanaka M; Hisaka T; Takazawa T; Kojiro M
    J Gastroenterol Hepatol; 1996 Aug; 11(8):758-64. PubMed ID: 8872774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology.
    Park HS; Bae JS; Jang KY; Lee JH; Yu HC; Jung JH; Cho BH; Chung MJ; Moon WS
    J Korean Med Sci; 2011 Aug; 26(8):1023-30. PubMed ID: 21860552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.